Whole body imaging in the abdominal cancer patient: Pitfalls of PET-CT

Abdominal Imaging

Volumn 35, Issue 1, 2010, Pages 55-69

  McDermott, Shaunagh ^a   Skehan, Stephen J ^a  

^a ST VINCENT S UNIVERSITY HOSPITAL   (Ireland)

Author keywords

Abdomen; Diagnosis; Fluorodeoxyglucose F18; Neoplasms; Normal variants; Pitfalls; Positron emission tomography; X ray computed tomography

Indexed keywords

FLUORODEOXYGLUCOSE F 18; TRACER;

ABDOMINAL CANCER; ADRENAL GLAND; ATTENUATION; BLADDER DISTENSION; BONE; BREATHING; CANCER PATIENT; COLON; COMPUTER ASSISTED EMISSION TOMOGRAPHY; DIAGNOSTIC IMAGING; DIAGNOSTIC PROCEDURE; HUMAN; IMAGE QUALITY; INTESTINE MOTILITY; JOINT; LIVER; MOTION; MUSCLE; OVARY; PANCREAS; PELVIS; PRIORITY JOURNAL; PROSTATE; REVIEW; SMALL INTESTINE; SPLEEN; STOMACH; TECHNOLOGY; TESTIS; URINARY TRACT; UTERUS; WHOLE BODY IMAGING;

ABDOMINAL NEOPLASMS; ARTIFACTS; FALSE POSITIVE REACTIONS; FLUORODEOXYGLUCOSE F18; HUMANS; POSITRON-EMISSION TOMOGRAPHY; RADIATION-PROTECTIVE AGENTS; TOMOGRAPHY, X-RAY COMPUTED; WHOLE BODY IMAGING;

EID: 76649106451     PISSN: 09428925     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00261-008-9493-4     Document Type: Review

References (30)

1. J Czernin M Allen-Auerbach HR Schelbert 2007 Improvements in cancer staging with PET/CT: literature-based evidence as of September 2006 J Nucl Med 48 Suppl 1 78S 88S 1:CAS:528:DC%2BD2sXitVamsrw%3D 17204723
2. C Cohade M Osman J Leal RL Wahl 2003 Direct comparison of (18)F-FDG PET and PET/CT in patients with colorectal carcinoma J Nucl Med 44 11 1797 1803 14602862
3. MA Blake A Singh BN Setty, et al. 2006 Pearls and pitfalls in interpretation of abdominal and pelvic PET-CT Radiographics 26 5 1335 1353 10.1148/rg.265055208 16973768 (Pubitemid 44518767)
4. MM Osman C Cohade Y Nakamoto, et al. 2003 Clinically significant inaccurate localization of lesions with PET/CT: frequency in 300 patients J Nucl Med 44 2 240 243 12571215
5. WV Vogel JA van Dalen B Wiering, et al. 2007 Evaluation of image registration in PET/CT of the liver and recommendations for optimized imaging J Nucl Med. 48 6 910 919 10.2967/jnumed.107.041517 17504865 (Pubitemid 46909919)
6. J Emmott B Sanghera J Chambers WL Wong 2008 The effects of N-butylscopolamine on bowel uptake: an 18F-FDG PET study Nucl Med Commun 29 1 11 16 10.1097/MNM.0b013e3282f1d706 18049092 (Pubitemid 351339335)
7. V Kapoor BM McCook FS Torok 2004 An introduction to PET-CT imaging Radiographics 24 2 523 543 10.1148/rg.242025724 15026598
8. W Sureshbabu O Mawlawi 2005 PET/CT imaging artifacts J Nucl Med Technol 33 3 156 161 16145223 quiz 63-64
9. J Trojan O Schroeder J Raedle, et al. 1999 Fluorine-18 FDG positron emission tomography for imaging of hepatocellular carcinoma Am J Gastroenterol 94 11 3314 3319 10.1111/j.1572-0241.1999.01544.x 1:STN:280: DC%2BD3c%2FjtFSisA%3D%3D 10566736
10. CD Anderson MH Rice CW Pinson, et al. 2004 Fluorodeoxyglucose PET imaging in the evaluation of gallbladder carcinoma and cholangiocarcinoma J Gastrointest Surg 8 1 90 97 10.1016/j.gassur.2003.10.003 14746840 (Pubitemid 38117282)
11. JY Kim MH Kim TY Lee, et al. 2008 Clinical role of 18F-FDG PET-CT in suspected and potentially operable cholangiocarcinoma: a prospective study compared with conventional imaging Am J Gastroenterol 103 5 1145 1151 10.1111/j.1572-0241.2007.01710.x 18177454 (Pubitemid 351677961)
12. JN Rini JC Leonidas MB Tomas CJ Palestro 2003 18F-FDG PET versus CT for evaluating the spleen during initial staging of lymphoma J Nucl Med 44 7 1072 1074 12843223
13. Y Sugawara KR Zasadny PV Kison LH Baker RL Wahl 1999 Splenic fluorodeoxyglucose uptake increased by granulocyte colony-stimulating factor therapy: PET imaging results J Nucl Med 40 9 1456 1462 1:CAS:528: DyaK1MXmtlOru7c%3D 10492365
14. MB Lustberg O Aras BR Meisenberg 2008 FDG PET/CT findings in acute adult mononucleosis mimicking malignant lymphoma Eur J Haematol 81 2 154 156 10.1111/j.1600-0609.2008.01088.x 18462255 (Pubitemid 352019632)
15. Y Nakamoto T Saga T Ishimori, et al. 2000 FDG-PET of autoimmune-related pancreatitis: preliminary results Eur J Nucl Med 27 12 1835 1838 10.1007/s002590000370 1:STN:280:DC%2BD3M7ltlagtw%3D%3D 11189947
16. R Bares P Klever S Hauptmann, et al. 1994 F-18 fluorodeoxyglucose PET in vivo evaluation of pancreatic glucose metabolism for detection of pancreatic cancer Radiology 192 1 79 86 1:STN:280:DyaK2c3mvFehsw%3D%3D 8208970
17. H Friess J Langhans M Ebert, et al. 1995 Diagnosis of pancreatic cancer by 2[18F]-fluoro-2-deoxy-D-glucose positron emission tomography Gut 36 5 771 777 10.1136/gut.36.5.771 1:STN:280:DyaK2MzhslKltw%3D%3D 7797130
18. M Yun W Kim N Alnafisi, et al. 2001 18F-FDG PET in characterizing adrenal lesions detected on CT or MRI J Nucl Med 42 12 1795 1799 1:STN:280: DC%2BD38%2FgtlOhuw%3D%3D 11752075
19. S Maurea C Mainolfi L Bazzicalupo, et al. 1999 Imaging of adrenal tumors using FDG PET: comparison of benign and malignant lesions AJR Am J Roentgenol 173 1 25 29 1:STN:280:DyaK1MzitlahsQ%3D%3D 10397094
20. BL Shulkin NW Thompson B Shapiro IR Francis JC Sisson 1999 Pheochromocytomas: imaging with 2-[fluorine-18]fluoro-2-deoxy-d-glucose PET Radiology 212 1 35 41 1:STN:280:DyaK1MzjsVWruw%3D%3D 10405717
21. HW Yeung RK Grewal M Gonen H Schoder SM Larson 2003 Patterns of (18)F-FDG uptake in adipose tissue and muscle: a potential source of false-positives for PET J Nucl Med 44 11 1789 1796 14602861
22. MM Abouzied ES Crawford HA Nabi 2005 18F-FDG imaging: pitfalls and artifacts J Nucl Med Technol 33 3 145 155 16145222 quiz 62-63
23. HB Prabhakar DV Sahani AJ Fischman PR Mueller MA Blake 2007 Bowel hot spots at PET-CT Radiographics 27 1 145 159 10.1148/rg.271065080 17235004
24. 18F-fluorodeoxyglucose positron tomography in diagnosis of paediatric inflammatory bowel disease Lancet 354 9181 836 837 10.1016/S0140-6736(99)80021- X 1:STN:280:DyaK1MvhtlOnsQ%3D%3D 10485733 (Pubitemid 29415596)
25. A Hannah AM Scott T Akhurst, et al. 1996 Abnormal colonic accumulation of fluorine-18-FDG in pseudomembranous colitis J Nucl Med 37 10 1683 1685 1:STN:280:DyaK2s%2FhsFKlsA%3D%3D 8862310
26. PD Shreve Y Anzai RL Wahl 1999 Pitfalls in oncologic diagnosis with FDG PET imaging: physiologic and benign variants Radiographics 19 1 61 77 1:STN:280:DyaK1M7it1yjsw%3D%3D 9925392 quiz 150-151
27. HJ Vesselle FD Miraldi 1998 FDG PET of the retroperitoneum: normal anatomy, variants, pathologic conditions, and strategies to avoid diagnostic pitfalls Radiographics 18 4 805 823 1:STN:280:DyaK1czjs1ygug%3D%3D 9672967 discussion 23-24
28. H Lerman U Metser D Grisaru, et al. 2004 Normal and abnormal 18F-FDG endometrial and ovarian uptake in pre- and postmenopausal patients: assessment by PET/CT J Nucl Med 45 2 266 271 14960646
29. N Subhas PV Patel HK Pannu, et al. 2005 Imaging of pelvic malignancies with in-line FDG PET-CT: case examples and common pitfalls of FDG PET Radiographics 25 4 1031 1043 10.1148/rg.254045155 16009822
30. A Turlakow HW Yeung AS Salmon HA Macapinlac SM Larson 2003 Peritoneal carcinomatosis: role of (18)F-FDG PET J Nucl Med 44 9 1407 1412 12960184